BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20215562)

  • 21. Insights into the UDP-sugar selectivities of human UDP-glycosyltransferases (UGT): a molecular modeling perspective.
    Nair PC; Meech R; Mackenzie PI; McKinnon RA; Miners JO
    Drug Metab Rev; 2015 Aug; 47(3):335-45. PubMed ID: 26289097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human UDP glucuronosyltransferase, UGT1A10, glucuronidates mycophenolic acid.
    Mojarrabi B; Mackenzie PI
    Biochem Biophys Res Commun; 1997 Sep; 238(3):775-8. PubMed ID: 9325166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.
    Barre L; Fournel-Gigleux S; Finel M; Netter P; Magdalou J; Ouzzine M
    FEBS J; 2007 Mar; 274(5):1256-64. PubMed ID: 17263731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and characterization of a canine UDP-glucuronosyltransferase.
    Soars MG; Smith DJ; Riley RJ; Burchell B
    Arch Biochem Biophys; 2001 Jul; 391(2):218-24. PubMed ID: 11437353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Required buried alpha-helical structure in the bilirubin UDP-glucuronosyltransferase, UGT1A1, contains a nonreplaceable phenylalanine.
    Ciotti M; Cho JW; George J; Owens IS
    Biochemistry; 1998 Aug; 37(31):11018-25. PubMed ID: 9692996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase (UGT1A1) activity.
    Basu NK; Kole L; Owens IS
    Biochem Biophys Res Commun; 2003 Mar; 303(1):98-104. PubMed ID: 12646172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan.
    Alonen A; Finel M; Kostiainen R
    Biochem Pharmacol; 2008 Sep; 76(6):763-72. PubMed ID: 18674515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilirubin UDP-glucuronosyltransferase 1A1 gene polymorphisms: susceptibility to oxidative damage and cancer?
    Grant DJ; Bell DA
    Mol Carcinog; 2000 Dec; 29(4):198-204. PubMed ID: 11170257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics.
    Zhang H; Patana AS; Mackenzie PI; Ikushiro S; Goldman A; Finel M
    Drug Metab Dispos; 2012 Oct; 40(10):1935-44. PubMed ID: 22782802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.
    Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO
    Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.
    Dong D; Ako R; Hu M; Wu B
    Xenobiotica; 2012 Aug; 42(8):808-20. PubMed ID: 22385482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic key amino acids and UDP-sugar donor specificity of a plant glucuronosyltransferase, UGT94B1: molecular modeling substantiated by site-specific mutagenesis and biochemical analyses.
    Osmani SA; Bak S; Imberty A; Olsen CE; Møller BL
    Plant Physiol; 2008 Nov; 148(3):1295-308. PubMed ID: 18829982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases.
    Patana AS; Kurkela M; Finel M; Goldman A
    Protein Eng Des Sel; 2008 Sep; 21(9):537-43. PubMed ID: 18502788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of the substrate UDP-glucuronic acid induces conformational changes in the xanthan gum glucuronosyltransferase.
    Salinas SR; Petruk AA; Brukman NG; Bianco MI; Jacobs M; Marti MA; Ielpi L
    Protein Eng Des Sel; 2016 Jun; 29(6):197-207. PubMed ID: 27099353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photoaffinity labeling studies of the human recombinant UDP-glucuronosyltransferase, UGT1*6, with 5-azido-UDP-glucuronic acid.
    Battaglia E; Nowell S; Drake RR; Magdalou J; Fournel-Gigleux S; Senay C; Radominska A
    Drug Metab Dispos; 1997 Apr; 25(4):406-11. PubMed ID: 9107538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2.
    Walle T; Otake Y; Galijatovic A; Ritter JK; Walle UK
    Drug Metab Dispos; 2000 Sep; 28(9):1077-82. PubMed ID: 10950852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico modeling of UDP-glucuronosyltransferase 1A10 substrates using the VolSurf approach.
    Dong D; Wu B
    J Pharm Sci; 2012 Sep; 101(9):3531-9. PubMed ID: 22388963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and function of uridine diphosphate glucuronosyltransferases.
    Meech R; Mackenzie PI
    Clin Exp Pharmacol Physiol; 1997 Dec; 24(12):907-15. PubMed ID: 9406655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
    Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
    J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.